A robust machine learning approach to predicting remission and stratifying risk in rheumatoid arthritis patients treated with bDMARDs

Abstract Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting millions worldwide, leading to inflammation, joint damage, and reduced quality of life. Although biological disease-modifying antirheumatic drugs (bDMARDs) are effective, they are costly, and up to 40% of patients do not ac...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatemeh Salehi, Emmanuelle Salin, Benjamin Smarr, Sara Bayat, Arnd Kleyer, Georg Schett, Ruth Fritsch-Stork, Bjoern M. Eskofier
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-025-09975-z
Tags: Add Tag
No Tags, Be the first to tag this record!